Novo Nordisk hits $500 billion in market value as it flags soaring demand for Wegovy, Ozempic

Liselotte Sabroe | Afp | Getty ImagesNovo Nordisk on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular anti-obesity and diabetes drugs continued to soar.The maker of weight loss drug Wegovy and diabetes drug Ozempic reported an increase in sales of 31% in Danish kroner and 36%...

Read more...

LVMH shares jump 12% as earnings point to luxury sector resilience

Bernard Arnault, Chairman and CEO of LVMH Moet Hennessy Louis Vuitton, speaks during a press conference to present the 2023 annual results of LVMH in Paris, France, January 25, 2024. Benoit Tessier | ReutersLVMH shares jumped more than 12% on Friday morning, after the world's largest luxury group posted higher-than-expected...

Read more...